A Common Variant on Chromosome 9p21 Affects the Risk of Myocardial Infarction
The DOI matches its Crossref record; 10 of the 11 references it cites were found in a registry or an index.
Abstract
The global endemic of cardiovascular diseases calls for improved risk assessment and treatment. Here, we describe an association between myocardial infarction (MI) and a common sequence variant on chromosome 9p21. This study included a total of 4587 cases and 12,767 controls. The identified variant, adjacent to the tumor suppressor genes CDKN2A and CDKN2B , was associated with the disease with high significance. Approximately 21% of individuals in the population are homozygous for this variant, and their estimated risk of suffering myocardial infarction is 1.64 times as great as that of noncarriers. The corresponding risk is 2.02 times as great for early-onset cases. The population attributable risk is 21% for MI in general and 31% for early-onset cases.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“and has also been robustly associated with CHD outcomes.(40-42)”
From Endometriosis and Risk of Coronary Heart Disease (2016) · cites this paper as [41]
In the citing paper
“Additionally, endometriosis and CHD may share common genetic susceptibilities.”
From Endometriosis and Risk of Coronary Heart Disease (2016) · cites this paper as [41]
In the citing paper
“Since 2007, genomewide association analyses have identified more than 50 independent loci associated with the risk of coronary artery disease.7–15”
From Genetic Risk, Adherence to a Healthy Lifestyle, and Coronary Disease (2016) · cites this paper as [8]
In the citing paper
“Interestingly, atherosclerotic plaques from patients carrying a genetic variation at the 9p21 locus (which includes the CDKN2B gene), which has been associated with atherosclerosis in humans204,205, have reduced levels of calreticulin compared with atherosclerotic plaques from non-carriers203, further supporting a role for defective efferocytosis in cardiovascular disease206.”
From Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities (2019) · cites this paper as [204]
In the citing paper
“Examples include the region at 8q24 associated with prostate, breast, and colon cancer, 300 kb from the nearest gene (103, 104), and the region at 9q21 associated with myocardial infarction and T2D, 150 kb from the nearest genes encoding CDKN2A and CDKN2B (99–101, 105–107).”
From Genetic Mapping in Human Disease (2008) · cites this paper as [107]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Statistical Aspects of the Analysis of Data From Retrospective Studies of Disease
(1959) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/22.4.719 · Cited by 14,689
Lusis, A. J. (2000) · Nature · doi:10.1038/35025203 · Cited by 4,839
Writing Group Members, Thom, T., Haase, N., Rosamond, W., Howard, V. J., Rumsfeld, J., Manolio, T., Zheng, Z.-J., Flegal, K., O’Donnell, C., et al. (2006) · Circulation · doi:10.1161/circulationaha.105.171600 · Cited by 3,451
Genomic Control for Association Studies
Devlin, B., & Roeder, K. (1999) · Biometrics · doi:10.1111/j.0006-341x.1999.00997.x · Cited by 3,162
The Regulation of INK4/ARF in Cancer and Aging
Kim, W. Y., & Sharpless, N. E. (2006) · Cell · doi:10.1016/j.cell.2006.10.003 · Cited by 1,009
Vascular Cell Senescence: Contribution to Atherosclerosis
Minamino, T., & Komuro, I. (2007) · Circulation Research · doi:10.1161/01.res.0000256837.40544.4a · Cited by 542
Heritability of death from coronary heart disease: a 36‐year follow‐up of 20 966 Swedish twins
Zdravkovic, S., Wienke, A., Pedersen, N. L., Marenberg, M. E., Yashin, A. I., & De Faire, U. (2002) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2002.01029.x · Cited by 511
Wang, Q., Rao, S., Shen, G.-Q., Li, L., Moliterno, D. J., Newby, L. K., Rogers, W. J., Cannata, R., Zirzow, E., Elston, R. C., et al. (2004) · The American Journal of Human Genetics · doi:10.1086/381560 · Cited by 217
Samani, N. J. (2005) · The American Journal of Human Genetics · doi:10.1086/498653 · Cited by 126
Zintzaras, E., & Kitsios, G. D. (2006) · Journal of Human Genetics · doi:10.1007/s10038-006-0053-x · Cited by 24
Research works printed but not linked: 2
- T. Thom et al., Circulation113, e85 (2006).
- N. Mantel, W. Haenszel, J. Natl. Cancer Inst.22, 719 (1959).
Cited by
Items 801–900 of 1,001
Wang, W., Oh, S., Koester, M., Abramowicz, S., Wang, N., Tall, A. R., & Welch, C. L. (2016) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.115.001294 · Cited by 18
Paleogenetic study on the 17th century Korean mummy with atherosclerotic cardiovascular disease
Shin, D. H., Oh, C. S., Hong, J. H., Kim, Y., Lee, S. D., & Lee, E. (2017) · PLoS ONE · doi:10.1371/journal.pone.0183098 · Cited by 22
Schisler, J. C., Charles, P. C., Parker, J. S., Hilliard, E., Mapara, S., Meredith, D., Lineberger, R. E., Wu, S., Alder, B. D., Stouffer, G. A., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0008183 · Cited by 20
A Clinical Approach to Inherited Premature Coronary Artery Disease
Stitziel, N. O., & MacRae, C. A. (2014) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.113.000152 · Cited by 23
Wood, G. C., Still, C. D., Chu, X., Susek, M., Erdman, R., Hartman, C., Yeager, S. F., Blosky, M. A., Krum, W., Carey, D. J., et al. (2008) · Genomic Medicine · doi:10.1007/s11568-008-9023-z · Cited by 19
“…same region of chromosome 9p21 which has previously been associated with T2D (Saxena et al. 2007; Scott et al. 2007; Zeggini et al. 2007) and CHD (Helgadottir et al. 2007; Larson et al. 2007; McPherson et al. 2007; O’Donnell et al. 2007; Samani et al. 2007) in genome wide association studies,…”
BackgroundA distant, cis-acting enhancer drives induction of Arf by Tgfβ in the developing eye
Zheng, Y., Devitt, C. C., Liu, J., Mei, J., & Skapek, S. X. (2013) · Developmental Biology · doi:10.1016/j.ydbio.2013.05.003 · Cited by 21
Farzaneh‐Far, R., Na, B., Schiller, N. B., & Whooley, M. A. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.12.026 · Cited by 19
An optimal dose‐effect mode trend test for SNP genotype tables
Yamada, R., & Okada, Y. (2008) · Genetic Epidemiology · doi:10.1002/gepi.20362 · Cited by 19
Guo, J. C., Li, W., Wu, Z., Cheng, X., Wang, Y., & Chen, T. (2012) · Molecular Biology Reports · doi:10.1007/s11033-012-2066-1 · Cited by 18
“In 2007, genome-wide association studies on CVD identified a series of associated single-nucleotide polymorphisms (SNPs) in an intergenic region of chromosome 9p21, near the CDKN2A and CDKN2B genes [6, 7].”
BackgroundMcPherson, R. (2012) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2012.08.017 · Cited by 24
Genetic variants for type 2 diabetes and new-onset cancer in Chinese with type 2 diabetes
Ma, R. C. W., So, W. Y., Tam, C. H. T., Luk, A. O. Y., Ho, J. S. K., Wang, Y., Lam, V. K. L., Lee, H. M., Kong, A. P. S., Tong, P. C. Y., et al. (2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2013.12.016 · Cited by 20
“[12] Helgadottir A, Thorleifsson G, Manolescu A, Gretarsdottir S, Blondal T, et al.”
BackgroundSelf-citationKhan, S. U., Saeed, S., Alsuhaibani, A. M., Fatima, S., Rehman, K. U., Zaman, U., Ullah, M., Refat, M. S. E.-D., & Lu, K. (2023) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2023.101821 · Cited by 23
Chromosome 9p21 rs10757278 polymorphism is associated with the risk of metabolic syndrome
Bayoğlu, B., Çakmak, H. A., Yüksel, H., Can, G., Karadağ, B., Ulutin, T., Vural, V. A., & Cengiz, M. (2013) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-013-1629-3 · Cited by 18
Chen, Z., Luzhan, Z., Ma, G., Jiahong, W., Xiaoli, Z., & Qi, Q. (2009) · Molecular Biology Reports · doi:10.1007/s11033-009-9479-5 · Cited by 16
The genetics of cardiovascular disease: new insights from emerging approaches
Chico, T., Milo, M., & Crossman, D. C. (2009) · The Journal of Pathology · doi:10.1002/path.2641 · Cited by 22
Becker, T., & Herold, C. (2009) · European Journal of Human Genetics · doi:10.1038/ejhg.2009.7 · Cited by 19
Peripheral Arterial Disease in Diabetes: Is There a Role for Genetics?
Katwal, A. B., & Dokun, A. O. (2011) · Current Diabetes Reports · doi:10.1007/s11892-011-0188-9 · Cited by 22
Zhang, L.-W., Li, J., Duan, F., Liu, Z., Zhan, S.-Y., Hu, Y., Jiang, J., Zhang, Y., Huo, Y., & Chen, D. (2014) · BMC Cardiovascular Disorders · doi:10.1186/1471-2261-14-170 · Cited by 19
The 9p21.3 locus and cardiovascular risk in familial hypercholesterolemia
Paquette, M., Chong, M., Saavedra, Y. G. L., Paré, G., Dufour, R., & Baass, A. W. (2017) · Journal of clinical lipidology · doi:10.1016/j.jacl.2017.01.012 · Cited by 19
Girelli, D., Piubelli, C., Martinelli, N., Corrocher, R., & Olivieri, O. (2017) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2017.03.019 · Cited by 19
Genetic Markers for Coronary Artery Disease
Veljković, N., Zarić, B. L., Đorić, I., Obradovic, M. M., Sudar-Milovanovic, E. M., Radak, D. J., & Isenović, E. R. (2018) · Medicina · doi:10.3390/medicina54030036 · Cited by 21
“25% of Europeans that carry two copies of this SNP have a 40% increased risk of atherosclerosis [93,94].”
BackgroundVariations of specific non-candidate genes and risk of myocardial infarction: A replication study
Koch, W., Hoppmann, P., Schömig, A., & Kastrati, A. (2009) · International Journal of Cardiology · doi:10.1016/j.ijcard.2009.07.028 · Cited by 18
Huang, M., Han, Y., Zhang, X., Pei, F., Deng, J., Kang, J., & Yan, C. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.11.004 · Cited by 19
Alsmadi, O. A., Muiya, P., Khalak, H. G., Al‐Saud, H., Meyer, B. F., Al-Mohanna, F. A., Alshahid, M., & Dzimiri, N. (2009) · Annals of Human Genetics · doi:10.1111/j.1469-1809.2009.00534.x · Cited by 25
“Several of these genes have also been associated with myocardial infarction (MI), an event which underlies such inflammatory processes and is a critical component in the pathogenesis of CAD (Helgadottir et al., 2006, 2007; Yamada, 2006; Yamada et al., 2006).”
BackgroundHistone Chaperone Jun Dimerization Protein 2 (JDP2): Role in Cellular Senescence and Aging
Huang, Y., Saito, S., & Yokoyama, K. K. (2010) · The Kaohsiung Journal of Medical Sciences · doi:10.1016/s1607-551x(10)70081-4 · Cited by 20
Topol, E. J., & Damani, S. B. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.06.023 · Cited by 18
Mantella, L. E., Singh, K. K., Sandhu, P., Kantores, C., Ramadan, A., Khyzha, N., Quan, A., Al-Omran, M. A., Fish, J. E., Jankov, R. P., et al. (2017) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-017-3065-2 · Cited by 20
High-Resolution Regulatory Maps Connect Vascular Risk Variants to Disease-Related Pathways
Åkerborg, Ö., Spalinskas, R., Pradhananga, S., Anil, A., Höjer, P., Poujade, F.-A., Folkersen, L., Eriksson, P. O., & Sahlén, P. (2019) · Circulation Genomic and Precision Medicine · doi:10.1161/circgen.118.002353 · Cited by 17
Association between ABO blood group and severity of coronary artery disease in unstable angina.
Omidi, N., Khorgami, M., Effatpanah, M., Khatami, F., Mashhadizadeh, M., Jalali, A., & Hekmat, H. (2017) · PubMed Central · Cited by 18
Ma, L., Chandel, N., Ermel, R., Sukhavasi, K., Hao, K., Ruusalepp, A., Björkegren, J., & Kovacic, J. C. (2020) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2020.08.013 · Cited by 17
Malinowski, D., Bochniak, O., Luterek-Puszyńska, K., Puszyński, M., & Pawlik, A. (2023) · Genes · doi:10.3390/genes14071425 · Cited by 25
Lusk, C. M., Dyson, G. E., Clark, A. G., Ballantyne, C. M., Frikke‐Schmidt, R., Tybjærg‐Hansen, A., Boerwinkle, E., & Sing, C. F. (2014) · Human Genetics · doi:10.1007/s00439-014-1451-3 · Cited by 17
Beckie, T. M., Groër, M. W., & Beckstead, J. W. (2011) · Genetic Testing and Molecular Biomarkers · doi:10.1089/gtmb.2010.0222 · Cited by 18
Gioli‐Pereira, L., Santos, P. C. J. L., Ferreira, N. E., Hueb, W. A., Krieger, J. E., & Pereira, A. C. (2012) · BMC Cardiovascular Disorders · doi:10.1186/1471-2261-12-61 · Cited by 17
Dandona, S., Chen, L., Fan, M., Alam, M. A., Assogba, O., Bélanger, M., Williams, K., Wells, G. A., Tang, W. H. W., Ellis, S. G., et al. (2009) · Human Genetics · doi:10.1007/s00439-009-0761-3 · Cited by 17
“3 (Helgadottir et al. 2007; Samani et al. 2007; McPherson et al. 2007).”
A Genetics Primer for Social Health Research
Way, B. M., & Gurbaxani, B. M. (2008) · Social and Personality Psychology Compass · doi:10.1111/j.1751-9004.2008.00084.x · Cited by 19
Yamada, Y., Sakuma, J., Takeuchi, I., Yasukochi, Y., Kato, K., Oguri, M., Fujimaki, T., Horibe, H., Muramatsu, M., Sawabe, M., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.16536 · Cited by 17
Kashyap, S., Kumar, S., Agarwal, V., Misra, D. P., Rai, M. K., & Kapoor, A. (2018) · Gene · doi:10.1016/j.gene.2018.01.021 · Cited by 17
Ding, X., & Guo, X. (2018) · Big Data Mining and Analytics · doi:10.26599/bdma.2018.9020015 · Cited by 20
Expression analysis of inflammatory response-associated genes in coronary artery disease
Ebadi, N., Ghafouri‐Fard, S., Taheri, M. N., Arsang‐Jang, S., & Omrani, M. D. (2020) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2019.1708953 · Cited by 18
“Antisense noncoding RNA in the INK4 locus (ANRIL), also known as CKDN2B-AS, is a long noncoding RNA (lncRNA) transcribed from 9p21 locus, which is one of the most important genetic susceptibility loci for CAD (Helgadottir et al. 2007, McPherson et al. 2007).”
BackgroundHigh Expression Levels of the SOCS3 Gene Are Associated with Acute Myocardial Infarction
Meng, H., Wang, X., Ruan, J., Chen, W., Meng, F., & Yang, P. (2020) · Genetic Testing and Molecular Biomarkers · doi:10.1089/gtmb.2020.0040 · Cited by 17
“…the incidence of progression from stable coronary artery disease (SCAD) to AMI remains high, indicating that additional unknown or poorly studied risk factors may contribute to the occurrence of AMI (Helgadottir et al. , 2007; McPherson et al. , 2007; Ogawa et al. , 2010; Schunkert et al. , 2010).”
Hinohara, K., Ohtani, H., Nakajima, T., Sasaoka, T., Sawabe, M., Lee, B.-S., Ban, J., Park, J.-E., Izumi, T., & Kimura, A. (2009) · Journal of Human Genetics · doi:10.1038/jhg.2009.87 · Cited by 17
Reece, A. S., & Hulse, G. K. (2013) · Cardiovascular Toxicology · doi:10.1007/s12012-013-9204-4 · Cited by 17
Chen, Z., Ding, Z., Ma, G., Liu, N., & Qian, Q. (2010) · Molecular Biology Reports · doi:10.1007/s11033-010-9951-2 · Cited by 19
Versmissen, J., Oosterveer, D. M., Yazdanpanah, M., Dehghan, A., Hólm, H., Erdman, J., Aulchenko, Y. S., Þorleifsson, G., Schunkert, H., Huijgen, R., et al. (2014) · European Journal of Human Genetics · doi:10.1038/ejhg.2014.101 · Cited by 19
Gene–Diet Interactions in Cardiovascular Disease
Dimitriou, M., & Dedoussis, G. V. (2012) · Current Nutrition Reports · doi:10.1007/s13668-012-0020-4 · Cited by 19
Ichihara, S., Yamamoto, K., Asano, H., Nakatochi, M., Sukegawa, M., Ichihara, G., Izawa, H., Hirashiki, A., Takatsu, F., Umeda, H., et al. (2013) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.111.000027 · Cited by 19
Patel, A. P., & Natarajan, P. (2019) · Cardiovascular Research · doi:10.1093/cvr/cvz032 · Cited by 20
The discovery of genes implicated in myocardial infarction
Ouwehand, W. H. (2009) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2009.03441.x · Cited by 18
Haplotypes on 9p21 Modify the Risk for Coronary Artery Disease Among Indians
AshokKumar, M., Emmanuel, C., Dhandapany, P. S., Rani, D. S., SaiBabu, R., Cherian, K. M., & Kumarasamy Thangaraj, K. (2010) · DNA and Cell Biology · doi:10.1089/dna.2010.1046 · Cited by 17
The genetics of cardiovascular disease
Delles, C., McBride, M., Padmanabhan, S., & Dominiczak, A. F. (2008) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2008.07.010 · Cited by 23
A customized genetic approach to the number one killer: coronary artery disease
Roberts, R. (2008) · Current Opinion in Cardiology · doi:10.1097/hco.0b013e32830e6b4e · Cited by 18
Recent advances in the genetics and genomics of asthma and related traits
Abou‐Sleiman, P. M., & Hakonarson, H. H. (2010) · Current Opinion in Pediatrics · doi:10.1097/mop.0b013e328339553d · Cited by 17
A Genome-Wide Association Study Primer for Clinicians
Wang, T., & Wang, H. (2009) · Taiwanese Journal of Obstetrics and Gynecology · doi:10.1016/s1028-4559(09)60265-5 · Cited by 18
“Myocardial infarction Helgadottir et al [26] Science Illumina Yes”
BackgroundMethodMorgan, T. M., Xiao, L., Lyons, P. G., Kassebaum, B., Krumholz, H. M., & Spertus, J. A. (2008) · BMC Medical Genetics · doi:10.1186/1471-2350-9-66 · Cited by 17
Szpakowicz, A., Pepiński, W., Waszkiewicz, E., Maciorkowska, D., Skawrońska, M., Niemcunowicz‐Janica, A., Milewski, R. J., Dobrzycki, S., Musial, W. J., & Kamiński, K. A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0095513 · Cited by 17
RetractedA myocardin-adjacent lncRNA balances SRF-dependent gene transcription in the heart
Anderson, D. M., Anderson, K. M., Nelson, B. R., McAnally, J., Bezprozvannaya, S., Shelton, J. M., Bassel‐Duby, R., & Olson, E. N. (2021) · Genes & Development · doi:10.1101/gad.348304.121 · Cited by 17
“Nucleotide polymorphisms in noncoding regions containing lncRNAs have long been associated with an increased risk for developing cardiovascular disease (Helgadottir et al. 2007;McPherson et al. 2007; Samani et al. 2007).”
BackgroundFujimaki, T., Horibe, H., Oguri, M., Kato, K., & Yamada, Y. (2013) · Biomedical Reports · doi:10.3892/br.2013.190 · Cited by 20
Pan, Z., Fan, Z., Ma, J., Liu, H., Shen, L., He, B., & Zhang, M. (2019) · PubMed · Cited by 19
Use of Polygenic Risk Scores for Coronary Heart Disease in Ancestrally Diverse Populations
Dikilitas, O., Schaid, D. J., Tcheandjieu, C., Clarke, S. L., Assimes, T. L., & Kullo, I. J. (2022) · Current Cardiology Reports · doi:10.1007/s11886-022-01734-0 · Cited by 17
Sun, J., Zhou, L., Yang, T., Deng, B., Bao, Y.-L., Gu, L., Wang, H., & Wang, L. (2023) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2023/1696190 · Cited by 17
Szymczak, S., Igl, B.-W., & Ziegler, A. (2009) · Statistics in Medicine · doi:10.1002/sim.3695 · Cited by 16
Genetic basis of β‐cell dysfunction in man
Groop, L., & Lyssenko, V. (2009) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2009.01117.x · Cited by 19
Are 25 SNP s from the CARDIoGRAM study associated with ischaemic stroke?
Lövkvist, H., Sjögren, M., Höglund, P., Engström, G., Jern, C., Olsson, S., Smith, J. G., Hedblad, B., Andsberg, G., Delavaran, H., et al. (2013) · European Journal of Neurology · doi:10.1111/ene.12183 · Cited by 23
The sense and nonsense of direct-to-consumer genetic testing for cardiovascular disease
Janssens, A. C. J. W., Wilde, A. A. M., & van Langen, I. M. (2011) · Netherlands Heart Journal · doi:10.1007/s12471-010-0069-x · Cited by 21
Juni, R. P., de Abreu, R. C., & Martins, P. A. D. C. (2017) · Non-coding RNA Research · doi:10.1016/j.ncrna.2017.01.001 · Cited by 18
Precision Medicine in Non Communicable Diseases.
Hasanzad, M., Sarhangi, N., Meybodi, H. R. A., Nikfar, S., Khatami, F., & Larijani, B. A. (2019) · PubMed Central · doi:10.22088/ijmcm.bums.8.2.1 · Cited by 23
Kertai, M. D., Li, Y., Li, Y.-W., Ji, Y., Alexander, J. H., Newman, M. F., Smith, P. K., Joseph, D., Mathew, J. P., & Podgoreanu, M. V. (2015) · BMJ Open · doi:10.1136/bmjopen-2014-006920 · Cited by 17
Genomics of Cardiovascular Disease
Manace, L. C., Godiwala, T. N., & Babyatsky, M. W. (2009) · Mount Sinai Journal of Medicine A Journal of Translational and Personalized Medicine · doi:10.1002/msj.20151 · Cited by 19
Genetics of Atherothrombosis and Thrombophilia
Mälarstig, A., & Hamsten, A. (2010) · Current Atherosclerosis Reports · doi:10.1007/s11883-010-0101-z · Cited by 18
Li, N., Guo, Y., Hongmei, W., Zhi-tao, Y., Juhong, Z., Ling, Z., & Wen-li, L. (2010) · Archives of Medical Research · doi:10.1016/j.arcmed.2010.08.006 · Cited by 19
Circulating, Imaging, and Genetic Biomarkers in Cardiovascular Risk Prediction
Ge, Y., & Wang, T. J. (2011) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2012.03.007 · Cited by 17
Schmidt, B., Frölich, S., Dragano, N., Frank, M., Eisele, L., Pechlivanis, S., Forstner, A. J., Nöthen, M. M., Mahabadi, A. A., Erbel, R., et al. (2017) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.116.001441 · Cited by 19
The Genetics of Ischemic Heart Disease: From Current Knowledge to Clinical Implications
Elosúa, R., & Sayols-Baixeras, S. (2017) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2017.02.046 · Cited by 21
Kunnas, T. A., Piesanen, J., & Nikkari, S. T. (2018) · Genetic Testing and Molecular Biomarkers · doi:10.1089/gtmb.2017.0249 · Cited by 16
Genome-Wide Association Studies and Risk Scores for Coronary Artery Disease: Sex Biases
Byars, S., & Inouye, M. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-77932-4_38 · Cited by 17
Marian, A. J. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.10.020 · Cited by 16
Genome studies: Genetics by numbers
Baker, M. (2008) · Nature · doi:10.1038/451516a · Cited by 20
Chromosome 9p21.3 Locus for Coronary Artery Disease
McPherson, R. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.07.032 · Cited by 16
Golchin, M. M., Ghaderian, S. M. H., Akhavan‐Niaki, H., Jalalian, R., Heidari, L., & Salami, S. A. (2017) · PubMed Central · Cited by 16
Zhong, Y., Chen, L., Li, J., Yao, Y., Liu, Q., Niu, K., Ma, Y., & Xu, Y. (2021) · Medicine · doi:10.1097/md.0000000000024769 · Cited by 15
Identification of Candidate Long Noncoding RNAs Associated with Left Ventricular Hypertrophy
Zhang, L., Hamad, E. A., Vausort, M., Funakoshi, H., Feldman, A. M., Wagner, D. R., & Devaux, Y. (2014) · Clinical and Translational Science · doi:10.1111/cts.12234 · Cited by 15
Fuster, J. J., Molina-Sánchez, P., Jovani-Sales, D., Vinué, Á., Serrano, M., & Andrés, V. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.12.013 · Cited by 16
“Recent genomeide association studies have demonstrated that certain common ingle-nucleotide polymorphisms (SNPs) in the chromosome 9p21 egion confer increased risk of coronary artery disease and other therosclerotic conditions in humans [4–12].”
BackgroundGene polymorphisms associated with susceptibility to coronary artery disease in Han Chinese people
Liu, Y., Zhou, Y. W., Yang, J., Tu, Z. G., Ji, S. Y., Huang, Z., & Zhou, Z. J. (2014) · Genetics and Molecular Research · doi:10.4238/2014.april.8.4 · Cited by 15
“However, there is no evidence that CDKN2A and CDKN2B have effects on the incidence of CAD (McPherson et al., 2007; Helgadottir et al., 2007).”
BackgroundŞakalar, Ç., Gürbüz, E., Kalay, N., & Kaya, M. G. (2013) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.230.171 · Cited by 15
“3 (Helgadottir et al. 2007; McPherson et al. 2007; Samani et al. 2007). rs4977574 is an SNP on chromosome 9, band p21.”
BackgroundLandman, G. W. D., van Vliet‐Ostaptchouk, J. V., Kleefstra, N., van Hateren, K. J., Drion, I., Groenier, K. H., Gans, R. O. B., Snieder, H., Hofker, M. H., & Bilo, H. J. G. (2012) · Cardiovascular Diabetology · doi:10.1186/1475-2840-11-138 · Cited by 14
Functional evaluation of genetic variation in complex human traits
Peters, D. T., & Musunuru, K. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds363 · Cited by 15
Genetic and epigenetic associations of ANRIL with coronary artery disease and risk factors
Xu, B., Xu, Z., Chen, Y., Lu, N., Shu, Z., & Tan, X. (2021) · BMC Medical Genomics · doi:10.1186/s12920-021-01094-8 · Cited by 16
Novel Susceptibility Locus at 22q11 for Diabetic Nephropathy in Type 1 Diabetes
Wessman, M., Forsblom, C. M., Kaunisto, M. A., Söderlund, J., Ilonen, J., Sallinen, R., Hiekkalinna, T., Parkkonen, M., Maxwell, A. P., Tarnow, L., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024053 · Cited by 19
Hinohara, K., Nakajima, T., Sasaoka, T., Sawabe, M., Lee, B.-S., Ban, J., Park, J.-E., Izumi, T., & Kimura, A. (2009) · Journal of Human Genetics · doi:10.1038/jhg.2009.22 · Cited by 15
Superko, H. R., Roberts, R., Agatston, A. A., Frohwein, S. C., Reingold, J. S., White, T. J., Sninsky, J. J., Margolis, B., Momary, K. M., Garrett, B. C., et al. (2011) · Current Atherosclerosis Reports · doi:10.1007/s11883-011-0198-8 · Cited by 16
Yu, J., Yang, Y. P., Zhang, W., Wu, Z., Li, Y., Zhang, N., & Tan, L. (2010) · Clinica Chimica Acta · doi:10.1016/j.cca.2010.04.023 · Cited by 15
Epigenomes: The missing heritability in human cardiovascular disease?
Monte, E., & Vondriska, T. M. (2014) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.201400031 · Cited by 15
Zabalza, M., Subirana, I., Lluís-Ganella, C., Sayols-Baixeras, S., de Groot, E., Arnold, R. J., Cenarro, A., Ramos, R., Marrugat, J., & Elosúa, R. (2015) · Revista Española de Cardiología · doi:10.1016/j.recesp.2014.10.023 · Cited by 18
Large-Scale Genomic Biobanks and Cardiovascular Disease
Small, A., O’Donnell, C. J., & Damrauer, S. M. (2018) · Current Cardiology Reports · doi:10.1007/s11886-018-0969-8 · Cited by 17
Mollahosseini, M., Rahimi, M. H., Yekaninejad, M. S., Maghbooli, Z., & Mirzaei, K. (2019) · European Journal of Nutrition · doi:10.1007/s00394-018-1872-1 · Cited by 16
Rare variants and cardiovascular disease
Wain, L. V. (2014) · Briefings in Functional Genomics · doi:10.1093/bfgp/elu010 · Cited by 18
Cardiovascular GO Annotation Initiative Year 1 Report: Why Cardiovascular GO?
Lovering, R. C., Dimmer, E. C., Khodiyar, V., Barrell, D. G., Scambler, P. J., Hubank, M. J. F., Apweiler, R., & Talmud, P. J. (2008) · PROTEOMICS · doi:10.1002/pmic.200800078 · Cited by 16
Advances in genome-wide association study of coronary heart disease
Yang, Y., & Lu, X. (2010) · Hereditas (Beijing) · doi:10.3724/sp.j.1005.2010.00097 · Cited by 15
No large-effect low-frequency coding variation found for myocardial infarction
Holmen, O. L., Zhang, H., Zhou, W., Schmidt, E. M., Hovelson, D. H., Langhammer, A., Løchen, M., Ganesh, S. K., Mathiesen, E. B., VATTEN, L. J., et al. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu175 · Cited by 16
“CAD genetic risk score categories and risk for MI based on previously identified CAD SNPs.”
BackgroundInfluential
Metadata
- Authors
- Helgadottir, A., Thorleifsson, G., Manolescu, A., Gretarsdottir, S., Blondal, T., Jonasdottir, A., Jonasdottir, A., Sigurdsson, A., Baker, A., Palsson, A., Masson, G., Gudbjartsson, D. F., Magnusson, K. P., Andersen, K., Levey, A. I., Backman, V. M., Matthiasdottir, S., Jonsdottir, T., Palsson, S., Einarsdottir, H., Gunnarsdottir, S., Gylfason, A., Vaccarino, V., Hooper, W. C., Reilly, M. P., Granger, C. B., Austin, H., Rader, D. J., Shah, S. H., Quyyumi, A. A., Gulcher, J. R., Thorgeirsson, G., Thorsteinsdottir, U., Kong, A., & Stefansson, K.
- Affiliations
- deCODE genetics, Sturlugata 8, IS-101 Reykjavik, Iceland.
- deCODE Genetics (Iceland) (IS)
- Corresponding author
- Manolescu, Andrei
- Kong, Augustine
- ORCID
- Venue
- Science
- Published
- 2007-06-08
- Volume
- 316
- Issue
- 5830
- Pages
- 1491-1493
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2036198235
- Semantic Scholar
- c6c5bbe025441bb878530bbd85db55cb110ef15a
- Cited by
- 1,594
- References
- 11
- Citations by year
- 2026: 16 · 2025: 22 · 2024: 25 · 2023: 30 · 2022: 28 · 2021: 56 · 2020: 39 · 2019: 60 · 2018: 80 · 2017: 71 · 2016: 71 · 2015: 87 · 2014: 97 · 2013: 92 · 2012: 130
- FWCI
- 98.53
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Hirsla (Landspítali University Hospital) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Acute Myocardial Infarction Research
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Risk Factors
- Keywords
- myocardial infarction, chromosome 9p21, genetic susceptibility, CDKN2A, CDKN2B, tumor suppressor, single nucleotide polymorphisms, early-onset myocardial infarction, population attributable risk, cardiovascular risk
- MeSH terms
- Aged, Chromosome Mapping, Chromosomes, Human, Pair 9, Coronary Artery Disease, Female, Genotype, Haplotypes, Heterozygote, Homozygote, Humans, Male, Middle Aged, Myocardial Infarction, Risk Factors, Genetic Variation, Linkage Disequilibrium, Case-Control Studies, Age of Onset, Genes, p16, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.